Clinical trial

Local Injection and Systemic Therapy in the Treatment of NSCLC.

NCT06618391

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2024-10-08

PhasePHASE2

Study timeline

Study start (estimated)2024-10-08Date precision: day

Registry last updated2024-10-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

EnvafolimabDRUG

Recombinant human endostatinDRUG

recombinant human adenovirus type 5DRUG

Sponsors & collaborators

Henan Cancer Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06618391 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.